Medios completes Caelo deal. Medios stock falls 1.61 percent

Published on 10/01/2026 at 09:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Medios targets EUR 3.1 billion revenue by 2031. Medios stock costs EUR 11.03 on October 1, 2026, minus 1.61 percent versus EUR 11.21.

Moderne Pharma-Lagerhalle mit Mitarbeiter im Kittel und gekühlten Medikamentenschränken — Medios AG (DE000A1MMCC8) beliefert Apotheken über ein modernes Pharma-Großhandelslager mit Kühlzonen und Logistik, Illustration mit AI erstellt.

Medios (ISIN DE000A1MMCC8) was trading at EUR 11.03 at Lang & Schwarz on October 1, 2026 at 9:30 a.m. CEST, down EUR 0.18 or minus 1.61 percent versus the prior close of EUR 11.21. On the same date, EQS News reported that Medios completed its acquisition of 74.00 percent of Caesar & Loretz GmbH, known as Caelo, after antitrust clearance. The company also agreed options for the remaining 26.00 percent.

Caelo adds an API platform

The transaction gives Medios a German anchor for its European Compounding Essentials business, alongside Magis Pharma in Belgium and Metapharmaceutical in Spain. Caelo supplies active pharmaceutical ingredients, excipients and raw materials to pharmacies, hospitals and industrial customers.

EQS News said Caelo employs 240 people at GMP-certified sites in Hilden and Bonn and expects EUR 40.00 million in revenue for the current financial year. For Medios, the deal expands compounding capacity while adding procurement, cross-selling and European distribution opportunities.

2031 targets reshape earnings

Medios presented its strategy on September 29, 2026. According to Business Insider, the group targets EUR 3.1 billion in revenue by 2031, compared with EUR 2.1 billion in 2025. Adjusted EBITDA is targeted at EUR 170 million, versus EUR 87 million under the new definition for 2025.

The earnings mix is the key issue. Medios targets a 5.50 percent adjusted EBITDA margin by 2031, while Compounding is described as the higher-margin growth engine. Net debt to adjusted EBITDA stood at 1.32 times in the first half of 2026, below the company's internal ceiling of 2.00 times, according to the same strategy release.

Analyst target stays above the price

On September 30, 2026, finanzen.net reported that Deutsche Bank Research maintained a Buy rating and a EUR 16.00 price target. The target lies 45.06 percent above the Lang & Schwarz price, keeping the market's attention on execution, integration and margin expansion rather than revenue growth alone.

Stock trades at EUR 11.03

Medios was trading at EUR 11.03 at Lang & Schwarz on October 1, 2026 at 9:30 a.m. CEST, minus 1.61 percent versus the Lang & Schwarz prior close of EUR 11.21 on September 30, 2026. The shares are traded on the Regulated Market of the Frankfurt Stock Exchange in the Prime Standard and are included in the SDAX. The further course of trading is shown by the continuously updated real-time quote of Medios stock.